Bulletin
Investor Alert

New York Markets Open in:

Deciphera Pharmaceuticals Inc.

NAS: DCPH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 21, 2021, 4:54 p.m.

/zigman2/quotes/203556943/composite

$

34.04

Change

0.00 0.00%

Volume

Volume 6,699

Quotes are delayed by 20 min

/zigman2/quotes/203556943/composite

Previous close

$ 34.21

$ 34.04

Change

-0.17 -0.50%

Day low

Day high

$33.80

$35.00

Open

52 week low

52 week high

$26.20

$68.40

Open

Insider Actions for Deciphera Pharmaceuticals Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
10/04/2021 Matthew L. Sherman
EVP & Chief Medical Officer
2,659   Disposition at $33.17 per share. 88,199
05/03/2021 Michael D. Taylor
Director
300   Disposition at $46.75 per share. 14,025
05/03/2021 Michael D. Taylor
Director
7,700   Disposition at $46.07 per share. 354,739
05/03/2021 Michael D. Taylor
Director
5,646   Derivative/Non-derivative trans. at $3.95 per share. 22,301
05/03/2021 Michael D. Taylor
Director
2,354   Derivative/Non-derivative trans. at $1.89 per share. 4,449
04/20/2021 James A. Bristol
Director
1,700   Disposition at $45.6 per share. 77,520
04/20/2021 James A. Bristol
Director
1,700   Derivative/Non-derivative trans. at $3.95 per share. 6,715
04/19/2021 James A. Bristol
Director
1,300   Disposition at $46.66 per share. 60,658
04/19/2021 James A. Bristol
Director
4,000   Disposition at $46.13 per share. 184,520
04/19/2021 James A. Bristol
Director
5,300   Derivative/Non-derivative trans. at $3.95 per share. 20,935
04/12/2021 James A. Bristol
Director
5,217   Disposition at $44.09 per share. 230,017
04/12/2021 James A. Bristol
Director
9,483   Disposition at $43.7 per share. 414,407
04/12/2021 James A. Bristol
Director
14,700   Derivative/Non-derivative trans. at $3.95 per share. 58,065
04/01/2021 Michael D. Taylor
Director
906   Disposition at $46.72 per share. 42,328
04/01/2021 Michael D. Taylor
Director
4,994   Disposition at $45.69 per share. 228,175
04/01/2021 Michael D. Taylor
Director
2,100   Disposition at $44.8 per share. 94,080
04/01/2021 Michael D. Taylor
Director
8,000   Derivative/Non-derivative trans. at $1.89 per share. 15,120
03/18/2021 Steven L. Hoerter
President and CEO; Director
2,450   Derivative/Non-derivative trans. at $43.19 per share. 105,815
03/18/2021 Steven L. Hoerter
President and CEO; Director
700   Derivative/Non-derivative trans. at $42.39 per share. 29,673
03/01/2021 Michael D. Taylor
Director
1,104   Disposition at $44.68 per share. 49,326
03/01/2021 Michael D. Taylor
Director
6,896   Disposition at $43.94 per share. 303,010
03/01/2021 Michael D. Taylor
Director
8,000   Derivative/Non-derivative trans. at $1.89 per share. 15,120
02/16/2021 Daniel L. Flynn
Chief Scientific Officer
11,100   Award at $0 per share. 0
02/16/2021 Matthew L. Sherman
EVP & Chief Medical Officer
11,100   Award at $0 per share. 0
02/16/2021 Thomas P. Kelly
Chief Financial Officer
11,100   Award at $0 per share. 0
02/16/2021 Daniel L. Flynn
Chief Scientific Officer
508   Disposition at $48.87 per share. 24,825
02/16/2021 Matthew L. Sherman
EVP & Chief Medical Officer
132   Disposition at $48.87 per share. 6,450
02/16/2021 Thomas P. Kelly
Chief Financial Officer
524   Disposition at $48.87 per share. 25,607
02/01/2021 Michael D. Taylor
Director
800   Disposition at $45.96 per share. 36,768
02/01/2021 Michael D. Taylor
Director
4,518   Disposition at $45.64 per share. 206,201
02/01/2021 Michael D. Taylor
Director
2,682   Disposition at $44.34 per share. 118,919
02/01/2021 Michael D. Taylor
Director
8,000   Derivative/Non-derivative trans. at $1.89 per share. 15,120

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
1 Sales
0
2,659
Last 6 months
2 Purchases
3 Sales
8,000
10,659
Last 12 months
19 Purchases
35 Sales
174,297
143,988

Officers and Executives

Mr. Steven L. Hoerter
President, Chief Executive Officer & Director
Mr. Thomas P. Kelly
Chief Financial Officer, Treasurer & Executive VP
Dr. Matthew L. Sherman
Chief Medical Officer & Executive Vice President
Dr. Daniel L. Flynn
Chief Scientific Officer & Executive VP
Dr. Stephen B. Ruddy
Chief Technical Officer
Mr. Eric Haltom
Senior Vice President-Clinical Operations
Mr. Daniel C. Martin
Chief Commercial Officer
Ms. Jennifer Robinson
Head-Investor Relations
Ms. Caroline Chevalier
Vice President-Human Resources
Mr. Jeffrey M. Held
General Counsel & Senior Vice President
Mr. Jama Pitman
Vice President-Regulatory & Quality Assurance
Dr. James A. Bristol
Chairman
Dr. Susan L. Kelley
Independent Director
Mr. Ron Squarer
Independent Director
Mr. Franklin S. Friedman
Independent Director
Ms. Patricia L. Allen
Independent Director
Dr. Edward J. Benz
Independent Director
Mr. John R. Martin
Independent Director
Mr. Dennis L. Walsh
Independent Director
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.20%
  • /zigman2/quotes/201948298/composite BABA-5.69%
  • /zigman2/quotes/202092269/composite ENSC+36.10%
  • /zigman2/quotes/200164174/composite SNOA+74.50%
  • /zigman2/quotes/207683784/composite TIGR-10.38%
X
Powered by StockTwits
Link to MarketWatch's Slice.